ISBT 128 implementation plan for cellular therapy products

Paul Ashford, Pat Distler, Adrian Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbach, Zbigniew Szczepiorkowski, Phyllis Irene Warkentin

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics.

Original languageEnglish (US)
Pages (from-to)258-264
Number of pages7
JournalJournal of Clinical Apheresis
Volume22
Issue number5
DOIs
StatePublished - Nov 1 2007

Fingerprint

Licensure
Terminology
Publications
Therapeutics
Organizations
Equipment and Supplies

Keywords

  • Coding
  • ISBT 128
  • Implementation
  • Labeling
  • Terminology

ASJC Scopus subject areas

  • Hematology

Cite this

Ashford, P., Distler, P., Gee, A., Lankester, A., Larsson, S., Feller, I., ... Warkentin, P. I. (2007). ISBT 128 implementation plan for cellular therapy products. Journal of Clinical Apheresis, 22(5), 258-264. https://doi.org/10.1002/jca.20146

ISBT 128 implementation plan for cellular therapy products. / Ashford, Paul; Distler, Pat; Gee, Adrian; Lankester, Alan; Larsson, Stella; Feller, Irene; Loper, Kathy; Pamphilon, Derwood; Poston, Leigh; Rabe, Fran; Slaper-Cortenbach, Ineke; Szczepiorkowski, Zbigniew; Warkentin, Phyllis Irene.

In: Journal of Clinical Apheresis, Vol. 22, No. 5, 01.11.2007, p. 258-264.

Research output: Contribution to journalReview article

Ashford, P, Distler, P, Gee, A, Lankester, A, Larsson, S, Feller, I, Loper, K, Pamphilon, D, Poston, L, Rabe, F, Slaper-Cortenbach, I, Szczepiorkowski, Z & Warkentin, PI 2007, 'ISBT 128 implementation plan for cellular therapy products', Journal of Clinical Apheresis, vol. 22, no. 5, pp. 258-264. https://doi.org/10.1002/jca.20146
Ashford P, Distler P, Gee A, Lankester A, Larsson S, Feller I et al. ISBT 128 implementation plan for cellular therapy products. Journal of Clinical Apheresis. 2007 Nov 1;22(5):258-264. https://doi.org/10.1002/jca.20146
Ashford, Paul ; Distler, Pat ; Gee, Adrian ; Lankester, Alan ; Larsson, Stella ; Feller, Irene ; Loper, Kathy ; Pamphilon, Derwood ; Poston, Leigh ; Rabe, Fran ; Slaper-Cortenbach, Ineke ; Szczepiorkowski, Zbigniew ; Warkentin, Phyllis Irene. / ISBT 128 implementation plan for cellular therapy products. In: Journal of Clinical Apheresis. 2007 ; Vol. 22, No. 5. pp. 258-264.
@article{572ef9efb30e482385fd509886549851,
title = "ISBT 128 implementation plan for cellular therapy products",
abstract = "The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics.",
keywords = "Coding, ISBT 128, Implementation, Labeling, Terminology",
author = "Paul Ashford and Pat Distler and Adrian Gee and Alan Lankester and Stella Larsson and Irene Feller and Kathy Loper and Derwood Pamphilon and Leigh Poston and Fran Rabe and Ineke Slaper-Cortenbach and Zbigniew Szczepiorkowski and Warkentin, {Phyllis Irene}",
year = "2007",
month = "11",
day = "1",
doi = "10.1002/jca.20146",
language = "English (US)",
volume = "22",
pages = "258--264",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - ISBT 128 implementation plan for cellular therapy products

AU - Ashford, Paul

AU - Distler, Pat

AU - Gee, Adrian

AU - Lankester, Alan

AU - Larsson, Stella

AU - Feller, Irene

AU - Loper, Kathy

AU - Pamphilon, Derwood

AU - Poston, Leigh

AU - Rabe, Fran

AU - Slaper-Cortenbach, Ineke

AU - Szczepiorkowski, Zbigniew

AU - Warkentin, Phyllis Irene

PY - 2007/11/1

Y1 - 2007/11/1

N2 - The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics.

AB - The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics.

KW - Coding

KW - ISBT 128

KW - Implementation

KW - Labeling

KW - Terminology

UR - http://www.scopus.com/inward/record.url?scp=35549008045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35549008045&partnerID=8YFLogxK

U2 - 10.1002/jca.20146

DO - 10.1002/jca.20146

M3 - Review article

VL - 22

SP - 258

EP - 264

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 5

ER -